openPR Logo
Press release

Hemoglobinopathies Market to Grow at a CAGR of 10.0% during 2022-2030 - Business Market Insights

11-23-2022 08:15 PM CET | Health & Medicine

Press release from: Business Market Insights

Hemoglobinopathies Market

Hemoglobinopathies Market

The market crossed US$ 8984.17 million mark in 2022 and is expected to hit US$ 19266.15 million by 2030, recording a CAGR of 10.0% during the forecast period.

It is estimated that thalassemia affects around 4.4 per 10,000 live births globally. Moreover, around 40 million thalassemia carriers are present in India. The southern regions of Italy and Greece are the most likely areas to be affected in Europe. The Maldives has a particularly high prevalence of thalassemia in Asia, with about 16% of the population reported having the condition. Other countries with tropical climates also have higher rates of thalassemia, including Thailand. In addition, according to the CDC, the incidence of sickle cell disease trait in the US was found to be 15.5 cases per 1,000 births. In addition, sickle cell disease occurs in one out of every 365 African American births.

Get a Sample Report "Hemoglobinopathies Market " @ https://www.businessmarketinsights.com/sample/BMIRE00026794?utm_source=OpenPr&utm_medium=10614

Within the report, the hemoglobinopathies market is segmented into type, diagnostic, end user, and geography. By type, the market is further segmented into thalassemia, sickle cell disease, and others. By diagnostic, the market is categorized into hemoglobin isoelectric focusing, hemoglobin electrophoresis, high performance liquid chromatography, genetic testing, and hemoglobin solubility test. Based on end user, the market is divided into hospitals, diagnostic laboratories, and research laboratories. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Major key players covered in this Hemoglobinopathies Market report:

Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Sebia
Novartis AG
Sangamo Therapeutics, Inc.
Global Blood Therapeutics, Inc.
Novus Biologicals
bluebird bio, Inc.
Gamida Cell
Pfizer, Inc.

Type:
Thalassemia
Sickle Cell Disease
Others

Diagnostic:
Hemoglobin Isoelectric Focusing
Hemoglobin Electrophoresis
High Performance Liquid Chromatography
Genetic Testing
Hemoglobin Solubility Test

End User:
Hospitals
Diagnostic Laboratories
Research Laboratories

Get Full Report Copy: https://www.businessmarketinsights.com/reports/hemoglobinopathies-market

Hemoglobinopathies Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, during the forecast period of 2022 to 2030.

Major Key Points of Hemoglobinopathies Market
• Hemoglobinopathies Market Overview
• Hemoglobinopathies Market Competition
• Hemoglobinopathies Market, Revenue and Price Trend
• Hemoglobinopathies Market Analysis by Application
• Company Profiles and Key Figures in Hemoglobinopathies Market
• Market Dynamics
• Methodology and Data Source

Purchase a Copy of this research @ https://www.businessmarketinsights.com/buy/single/BMIRE00026794?utm_source=OpenPr&utm_medium=10614

Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position is explained to help make a well informed decision. Competitive landscape Hemoglobinopathies market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 analysis of markets and industries. Cordially get in touch for more details.

Contact us:

If you have any questions about this report or would like further information, please contact us:
Contact Person: Sameer Joshi
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market to Grow at a CAGR of 10.0% during 2022-2030 - Business Market Insights here

News-ID: 2819071 • Views:

More Releases from Business Market Insights

North America Demineralized Whey Powder Market Research Report
The North America demineralized whey powder market was valued at US$ 172.56 million in 2023 and is expected to reach US$ 241.68 million by 2031; it is estimated to record a CAGR of 4.3% from 2023 to 2031. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Demineralized Whey Powder Market 2031. in addition, the report within the market
North America Defibrillator Market Overview by Top Manufacturers 2028
The defibrillator market in North America is expected to grow from US$ 4,575.28 million in 2021 to US$ 6,597.93 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defibrillator Market 2028. in addition, the report within the market overview section outlines PLC
North America Defense Integrated Antenna Market Recent Trends by Forecast to 202 …
North America defense integrated antenna market is expected to grow from US$ 461.89 million in 2022 to US$ 707.29 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defense Integrated Antenna Market 2028. in addition, the report within the market overview section
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till 2031
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till …
The cancer chemotherapy market size is expected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024. The market is estimated to record a CAGR of 11.5% from 2025 to 2031. Europe Commercial Refrigeration Market Overview Executive Summary and Global Market Analysis: The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in

All 5 Releases


More Releases for Hemoglobin

Top Trends Transforming the Hemoglobin Meter Market Landscape in 2025: Advanceme …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Hemoglobin Meter Industry Market Size Be by 2025? The market size of the hemoglobin meter has witnessed a significant increase in recent times. The market is predicted to expand from $2.46 billion in 2024 to $2.75 billion in 2025, representing a compound annual growth rate (CAGR)
Transformative Trends Impacting the Hemoglobin Testing Market Landscape: Innovat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Hemoglobin Testing Market Size By 2025? In recent times, there has been a robust growth in the size of the hemoglobin testing market. The market, which was worth $2.64 billion in 2024 is projected to escalate to $2.81 billion in 2025, exhibiting a compound annual
Anemia Surge Boosts Hemoglobin Meter Market: An Emerging Driver Transforming The …
The Hemoglobin Meter Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Hemoglobin Meter Market? The hemoglobin meter market size will grow from $2.46 billion in 2024 to $2.75 billion in 2025 at a CAGR of 11.8%. Factors contributing to
Hemoglobin Testing Market Size, Share & Trends 2024-2033
The Business Research Company recently released a comprehensive report on the Global Hemoglobin Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The hemoglobin testing market size
Hemoglobin Testing Market
Hemoglobin Testing Market report gives detailed explanation of the estimations about the existing state of the market, market size and market share, revenue generated from the product sale, and necessary changes required in the future products are given in an appropriate way. A swiftly transforming market place increases the value of market research report and hence Hemoglobin Testing Market report has been created in a way that you anticipate. Skilled
Glycated Hemoglobin Testing Market : Lucrative Opportunities
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.